Abstract:Abstract B cells are essential components of humoral immunity but harbor multifaceted functions across cancers. To decode tumor-infiltrating B cells, we generated the B cell blueprint encompassing single-cell transcriptome, BCR repertoire, and chromatin accessibility data across 20 cancer types (483 samples, 266 patients). Strikingly, B cells harbored extraordinary heterogeneity and composed of 15 subsets, which were grouped into two independent developmental paths (extra-follicular [EF] versus germinal-center [GC]) exhibiting organ preference. Of note, colon adenocarcinoma and hepatocellular carcinoma are the two representative types of cancer enriched for GC and EF pathways, respectively. We affirm that EF-dominant cancers correlate with dysregulated immune responses and worse clinical outcomes. We then identify the dynamic metabolic-epigenetic-signaling networks in fine-tuning tumor-infiltrating B cell differentiation and managing the balance between the EF and GC pathways. Atypical memory (AtM) B cells, the primary progenitors of EF-derived ASCs, exhibit an exhausted and bystander phenotype and develop independently of the GC pathway. We find that the AtM B cells reside in the center of immature TLSs and spatially relocate to the periphery during TLS maturation. Finally, we mechanistically link these findings to specific transcription factors and epigenomic regulations. We demonstrate that the glutamine-derived metabolite α-ketoglutarate (αKG) could increase the expression of AtM B cell associated transcription factors Tbet and BATF and promote their differentiation, accompanied by the activation of mammalian target of rapamycin complex 1 (mTORC1) signaling. Consequently, AtM B cells acquire an immunoregulatory function that dampens anti-tumor T cell responses and fosters an immunosuppressive microenvironment. Citation Format: Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Guoji Guo, Jia Fan, Xiaoming Zhang, Qiang Gao. Cancer B cell blueprint reveals dysfunctional extra-follicular dominance with therapeutic opportunity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3973.

Landscape of B cell immunity and related immune evasion in human cancers

Abstract B92: Landscape of B-cell Immunity and Related Immune Evasion in Human Cancers

Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies

A Blueprint for Tumor-Infiltrating B Cells Across Human Cancers

Landscape of Tumor-Infiltrating T Cell Repertoire of Human Cancers.

The Landscape of Antigen-Specific T Cells in Human Cancers

The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma.

B cells and tumor immune escape.

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures

The Immune Landscape of Cancer

IGH Repertoire Analysis at Scale: Deciphering the Complexity of B Cell Infiltration and Migration in Esophageal Squamous Cell Carcinoma.

The emerging roles of B cells in cancer development

The Role of Tumor-Infiltrating B Cells in the Tumor Microenvironment of Hepatocellular Carcinoma and Its Prognostic Value: a Bioinformatics Analysis.

IGHA1 and IGHG1 expression panel predicts anti-PD-L1 response in muscle-invasive bladder cancer

Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer

Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.

Abstract 3973: Cancer B cell blueprint reveals dysfunctional extra-follicular dominance with therapeutic opportunity

Single-cell Landscape of Primary Central Nervous System Diffuse Large B-cell Lymphoma

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities